Related Experiment Videos
CSF shunts 50 years on--past, present and future
J M Drake1, J R Kestle, S Tuli
1Division of Neurosurgery, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. james.drake@sickkids.on.ca
Summary
Newer cerebrospinal fluid (CSF) shunt designs offer limited advantages over older models. Hydrocephalus shunt complications persist, necessitating rigorous scientific evaluation of new devices and treatments.
Area of Science:
- Neurosurgery
- Biomedical Engineering
- Pediatric Neurology
Background:
- Cerebrospinal fluid (CSF) shunts have been used for nearly 50 years to treat hydrocephalus.
- Despite numerous advancements, shunt complications remain a significant challenge.
- Previous shunt designs have shown limited impact on improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of new cerebrospinal fluid (CSF) shunt valve designs.
- To identify risk factors associated with shunt failure.
- To assess the impact of shunt design on ventricular size and changes.
Main Methods:
- A randomized trial comparing two new CSF shunt valves (Cordis Orbis Sigma and Medtronic PS Medical Delta) against standard designs.
- Post hoc analysis of trial data to identify risk factors for shunt failure.
- Evaluation of ventricular size and rate of change.
Main Results:
- Newer CSF shunt valves demonstrated no significant advantage in failure rates compared to standard designs.
- Hydrocephalus etiology and ventricular catheter tip placement were identified as key risk factors for shunt failure.
- No significant differences in ventricular size or rate of change were observed between the tested valves.
Conclusions:
- Current advancements in CSF shunt design have had a limited impact on reducing complications.
- Rigorous scientific scrutiny of new devices and treatments is crucial.
- Future research should focus on basic pathophysiology and improved animal models for shunt failure.